Cargando…

The diagnostic value of BI-RADS grade 3 to 5 for breast masses is correlated with the expression of estrogen receptor, progesterone receptor, human epidermal growth factor receptor-2

The breast imaging-reporting and data system (BI-RADS) grading has a great advantage in diagnosing breast diseases, but with some limitations. AIMS: The study analyzed the value of ultrasound-guided core needle biopsy (CNB) in diagnosing BI-RADS grades 3, 4, and 5 breast cancer. METHODS: Breast canc...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Tiejun, Shi, Tiemei, Luo, Wendong, Ju, Yabo, Li, Ran
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10313303/
https://www.ncbi.nlm.nih.gov/pubmed/37390283
http://dx.doi.org/10.1097/MD.0000000000033208
_version_ 1785067097158582272
author He, Tiejun
Shi, Tiemei
Luo, Wendong
Ju, Yabo
Li, Ran
author_facet He, Tiejun
Shi, Tiemei
Luo, Wendong
Ju, Yabo
Li, Ran
author_sort He, Tiejun
collection PubMed
description The breast imaging-reporting and data system (BI-RADS) grading has a great advantage in diagnosing breast diseases, but with some limitations. AIMS: The study analyzed the value of ultrasound-guided core needle biopsy (CNB) in diagnosing BI-RADS grades 3, 4, and 5 breast cancer. METHODS: Breast cancer patients at BI-RADS grades 3 to 5 received breast ultrasonography, ultrasound-guided CNB and immunohistochemical examination. Receiver operating characteristic (ROC) curve was made to test diagnostic efficiency of regression model. RESULTS: Calcification was positively correlated with expression of estrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor receptor (HER)-2. The areas of 4 ROC curves were 0.752, 0.805, 0.758, and 0.847, and the 95%CI was 0.660 to 0.844, 0.723 to 0.887, 0.667 to 0.849, and 0.776 to 0.918, respectively. BI-RADS grades 3 to 5 were positively correlated with expression of ER, PR and human epidermal growth factor receptor-2 (HER-2). Statistical significance existed between grade 5 and expression of ER, PR and HER-2, and between grade 4 and expression of HER-2. CONCLUSIONS: The study demonstrates that BI-RADS can be used as an effective evaluation method in the diagnosis of breast diseases before invasive operation, and it has higher diagnostic accuracy if combined with pathological examinations.
format Online
Article
Text
id pubmed-10313303
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-103133032023-07-01 The diagnostic value of BI-RADS grade 3 to 5 for breast masses is correlated with the expression of estrogen receptor, progesterone receptor, human epidermal growth factor receptor-2 He, Tiejun Shi, Tiemei Luo, Wendong Ju, Yabo Li, Ran Medicine (Baltimore) 6800 The breast imaging-reporting and data system (BI-RADS) grading has a great advantage in diagnosing breast diseases, but with some limitations. AIMS: The study analyzed the value of ultrasound-guided core needle biopsy (CNB) in diagnosing BI-RADS grades 3, 4, and 5 breast cancer. METHODS: Breast cancer patients at BI-RADS grades 3 to 5 received breast ultrasonography, ultrasound-guided CNB and immunohistochemical examination. Receiver operating characteristic (ROC) curve was made to test diagnostic efficiency of regression model. RESULTS: Calcification was positively correlated with expression of estrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor receptor (HER)-2. The areas of 4 ROC curves were 0.752, 0.805, 0.758, and 0.847, and the 95%CI was 0.660 to 0.844, 0.723 to 0.887, 0.667 to 0.849, and 0.776 to 0.918, respectively. BI-RADS grades 3 to 5 were positively correlated with expression of ER, PR and human epidermal growth factor receptor-2 (HER-2). Statistical significance existed between grade 5 and expression of ER, PR and HER-2, and between grade 4 and expression of HER-2. CONCLUSIONS: The study demonstrates that BI-RADS can be used as an effective evaluation method in the diagnosis of breast diseases before invasive operation, and it has higher diagnostic accuracy if combined with pathological examinations. Lippincott Williams & Wilkins 2023-06-30 /pmc/articles/PMC10313303/ /pubmed/37390283 http://dx.doi.org/10.1097/MD.0000000000033208 Text en Copyright © 2023 the Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY) (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle 6800
He, Tiejun
Shi, Tiemei
Luo, Wendong
Ju, Yabo
Li, Ran
The diagnostic value of BI-RADS grade 3 to 5 for breast masses is correlated with the expression of estrogen receptor, progesterone receptor, human epidermal growth factor receptor-2
title The diagnostic value of BI-RADS grade 3 to 5 for breast masses is correlated with the expression of estrogen receptor, progesterone receptor, human epidermal growth factor receptor-2
title_full The diagnostic value of BI-RADS grade 3 to 5 for breast masses is correlated with the expression of estrogen receptor, progesterone receptor, human epidermal growth factor receptor-2
title_fullStr The diagnostic value of BI-RADS grade 3 to 5 for breast masses is correlated with the expression of estrogen receptor, progesterone receptor, human epidermal growth factor receptor-2
title_full_unstemmed The diagnostic value of BI-RADS grade 3 to 5 for breast masses is correlated with the expression of estrogen receptor, progesterone receptor, human epidermal growth factor receptor-2
title_short The diagnostic value of BI-RADS grade 3 to 5 for breast masses is correlated with the expression of estrogen receptor, progesterone receptor, human epidermal growth factor receptor-2
title_sort diagnostic value of bi-rads grade 3 to 5 for breast masses is correlated with the expression of estrogen receptor, progesterone receptor, human epidermal growth factor receptor-2
topic 6800
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10313303/
https://www.ncbi.nlm.nih.gov/pubmed/37390283
http://dx.doi.org/10.1097/MD.0000000000033208
work_keys_str_mv AT hetiejun thediagnosticvalueofbiradsgrade3to5forbreastmassesiscorrelatedwiththeexpressionofestrogenreceptorprogesteronereceptorhumanepidermalgrowthfactorreceptor2
AT shitiemei thediagnosticvalueofbiradsgrade3to5forbreastmassesiscorrelatedwiththeexpressionofestrogenreceptorprogesteronereceptorhumanepidermalgrowthfactorreceptor2
AT luowendong thediagnosticvalueofbiradsgrade3to5forbreastmassesiscorrelatedwiththeexpressionofestrogenreceptorprogesteronereceptorhumanepidermalgrowthfactorreceptor2
AT juyabo thediagnosticvalueofbiradsgrade3to5forbreastmassesiscorrelatedwiththeexpressionofestrogenreceptorprogesteronereceptorhumanepidermalgrowthfactorreceptor2
AT liran thediagnosticvalueofbiradsgrade3to5forbreastmassesiscorrelatedwiththeexpressionofestrogenreceptorprogesteronereceptorhumanepidermalgrowthfactorreceptor2
AT hetiejun diagnosticvalueofbiradsgrade3to5forbreastmassesiscorrelatedwiththeexpressionofestrogenreceptorprogesteronereceptorhumanepidermalgrowthfactorreceptor2
AT shitiemei diagnosticvalueofbiradsgrade3to5forbreastmassesiscorrelatedwiththeexpressionofestrogenreceptorprogesteronereceptorhumanepidermalgrowthfactorreceptor2
AT luowendong diagnosticvalueofbiradsgrade3to5forbreastmassesiscorrelatedwiththeexpressionofestrogenreceptorprogesteronereceptorhumanepidermalgrowthfactorreceptor2
AT juyabo diagnosticvalueofbiradsgrade3to5forbreastmassesiscorrelatedwiththeexpressionofestrogenreceptorprogesteronereceptorhumanepidermalgrowthfactorreceptor2
AT liran diagnosticvalueofbiradsgrade3to5forbreastmassesiscorrelatedwiththeexpressionofestrogenreceptorprogesteronereceptorhumanepidermalgrowthfactorreceptor2